Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Outcomes Study of the Trabecular Metal (TM) Reverse Shoulder System

NCT: NCT01480440 · ACTIVE_NOT_RECRUITING

NCT IDNCT01480440
StatusACTIVE_NOT_RECRUITING
Start Date2011-01
Completion2026-12

Brief Summary

The objectives of this study are to obtain survival and outcome data on the Trabecular Metal Reverse Shoulder System when used in primary or revision reverse total shoulder arthroplasty.

Frequently Asked Questions

What is Outcomes Study of the Trabecular Metal (TM) Reverse Shoulder System?

Outcomes Study of the Trabecular Metal (TM) Reverse Shoulder System is a clinical trial registered under NCT01480440. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT01480440?

The current status of NCT01480440 (Outcomes Study of the Trabecular Metal (TM) Reverse Shoulder System) is: ACTIVE_NOT_RECRUITING.

When did Outcomes Study of the Trabecular Metal (TM) Reverse Shoulder System start?

Outcomes Study of the Trabecular Metal (TM) Reverse Shoulder System started on 2011-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑